Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2022-04-27 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith ....
Regulatory Filings
2022-04-27 English
Please find enclosed certificate under Regulation 40 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, issued by Mr. Praveen Dua, Practising Company ....
Regulatory Filings Classification · 95% confidence The document is a certificate issued pursuant to Regulation 40 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the financial year ended 31 March 2022. It certifies the timely issuance of share certificates and related documents by the company and its registrar. The document is a formal attestation by a practicing company secretary and does not contain financial statements or detailed financial data. It is primarily a regulatory compliance certificate related to share transfer processes, not a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and regulatory documents that do not fit other specific categories.
2022-04-23 English
Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we hereby confirm that all activities related to physical and electronic ....
Regulatory Filings
2022-04-19 English
We wish to clarify that the company has been regularly intimating all the compliances, to Stock Exchanges as per Regulation 30 of the SEBI (LODR) Regulations, 2015, as amended. We hereby ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to BSE Limited regarding clarification on price movement of the company's shares. It references compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure obligations. The letter states there are no pending price sensitive announcements or events. The document is short (1576 characters) and serves as a regulatory communication clarifying market rumors or price movements rather than a financial report or announcement of a report. It does not contain financial data, management changes, voting results, or other report types. It fits best as a Regulatory Filing (RNS) since it is a compliance-related disclosure that does not fit other specific categories.
2022-04-10 English
Price movement
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding a clarification on the movement in the company's share price. It references compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015, which pertains to disclosure obligations. The letter states that there are no pending price-sensitive announcements or events and attributes the price movement to market factors. The document is a regulatory communication clarifying a market surveillance query rather than a financial report, announcement of voting results, or management change. It does not contain financial data, earnings, or detailed report content. It is a regulatory filing to comply with stock exchange requirements and clarify information for surveillance purposes. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is short (1644 characters), consistent with a regulatory filing letter rather than a full report or announcement.
2022-04-09 English
Defaults on Payment of Interest/Principal
Regulatory Filings Classification · 95% confidence The document is a quarterly disclosure pursuant to SEBI Circular no. SEBI/HO/CFD/CMD1/CIR/P/2019/140 dated November 21, 2019, regarding the status of defaults on payment of interest/repayment of principal amount on loans from banks/financial institutions and unlisted debt securities as of March 31, 2022. It provides specific financial data about outstanding loans, defaults, and financial indebtedness. The document is not a full financial report like an Interim/Quarterly Report (IR) because it focuses solely on default status disclosures as required by a regulatory circular. It is not an earnings release or annual report. It is a regulatory compliance disclosure related to debt default status. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2022-04-07 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.